NDC codes

FDA NDC Directory
Product NDC (as listed)73070-200Labeler and product segments. Claims need a package NDC.
Product NDC at billing width73070-0200Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
73070-200-1173070020011730700200111 VIAL, GLASS in 1 CARTON (73070-200-11) / 10 mL in 1 VIAL, GLASSMarketed from Sep 10, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Insulin Aspart Protamine and Insulin Aspart Mix 70/30Suffix: Mix 70/30
Generic name (nonproprietary)
insulin aspart
Active ingredients
Insulin aspart — 100 [iU]/mL
Dosage form
Injection, Suspension
Route
Subcutaneous
Labeler
Novo Nordisk Pharma, Inc.NDC labeler code 73070
Product type
Prescription drug
Marketing category
BLA — Biologics License ApplicationApplication BLA 021172
Marketing start
Marketing end
Other FDA classes
Insulin (Chemical structure)
Identifiers
Product ID 73070-200_885b9016-188e-469d-926d-ae8019b69612SPL ID 885b9016-188e-469d-926d-ae8019b69612SPL set ID fc94baa4-3606-48bc-a781-9617ab6960efRxCUI 351297, 847191UNII D933668QVXUPC 0373070200114
Pharmacologic class
Insulin Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N473070020011 followed by a unit qualifier and the quantity

Package 73070-0200-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is a mixture of insulin aspart protamine and insulin aspart indicated to improve glycemic control in adult patients with diabetes mellitus. Limitations of Use: • Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is not recommended for the treatment of diabetic ketoacidosis. • The proportions of rapid-acting and long-acting insulins in Insulin Aspart Protamine and Insulin Aspart Mix 70/30 are fixed and do not allow for basal versus prandial dose adjustments. Insulin Aspart Protamine and Insulin Aspart Mix 70/30 is a mixture of insulin aspart protamine, an intermediate-acting human insulin analog, and insulin aspart, a rapid-acting huma…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73070-200

What is NDC 73070-200?
73070-200 is the product NDC for Insulin Aspart Protamine and Insulin Aspart Mix 70/30, Insulin aspart 100 [iU]/mL injection, suspension, listed with the FDA by Novo Nordisk Pharma, Inc.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Insulin Aspart Protamine and Insulin Aspart Mix 70/30 (Insulin aspart).
What is the active ingredient?
Insulin aspart.
Who is the labeler?
Novo Nordisk Pharma, Inc., NDC labeler code 73070. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Insulin Aspart Protamine and Insulin Aspart Mix 70/30?
2 other product NDCs are listed under this name. See all Insulin Aspart Protamine and Insulin Aspart Mix 70/30 NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Insulin Aspart Protamine and Insulin Aspart Mix 70/30 NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousREMEDYREPACK INC.70518-323670518-3236-00
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharma, Inc.73070-20373070-0203-15

Other NDCs under BLA 021172

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under BLA 021172
ProductStrengthForm · routeLabelerProduct NDC
.Insulin Aspart Protamine and Insulin Aspartinsulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousA-S Medication Solutions50090-4959
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousREMEDYREPACK INC.70518-3236
Insulin Aspart Protamine and Insulin Aspart Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharma, Inc.73070-203
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-2200
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-2201
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-3685
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousNovo Nordisk Pharmaceutical Industries, LP0169-3696
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousA-S Medication Solutions50090-2272
NovoLog Mix 70/30insulin aspartInsulin aspart 100 [iU]/mLInjection, SuspensionSubcutaneousREMEDYREPACK INC.70518-2119

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in